The use of digoxin in patients with worsening chronic heart failure: Reconsidering an old drug to reduce hospital admissions

Journal of the American College of Cardiology

Volumn 63, Issue 18, 2014, Pages 1823-1832

  Ambrosy, Andrew P ^a   Butler, Javed ^b   Ahmed, Ali ^c   Vaduganathan, Muthiah ^d   Van Veldhuisen, Dirk J ^e   Colucci, Wilson S ^f   Gheorghiade, Mihai ^g  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

Author keywords

digoxin; heart failure; hospitalized; morbidity; mortality

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DIGOXIN; PLACEBO; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

CARDIOVASCULAR RISK; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; HEART CONDUCTION; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART OUTPUT; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SURVIVAL; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL (TOPIC); DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; EMERGENCY WARD; HIGH RISK PATIENT; NEW YORK HEART ASSOCIATION CLASS; RETROSPECTIVE STUDY;

DIGOXIN; HEART FAILURE; HOSPITALIZED; MORBIDITY; MORTALITY;

ANIMALS; CARDIOTONIC AGENTS; CHRONIC DISEASE; DIGOXIN; HEART FAILURE; HOSPITALIZATION; HUMANS; TREATMENT OUTCOME;

EID: 84899881353     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.051     Document Type: Review

References (71)

1. W. Withering An account of the foxglove and some of its medical uses, with practical remarks on dropsy, and other diseases F.A. Willins, T.E. Keys, Classics of Cardiology. 1Volume I 1941 Henry Schuman, Dover Publications New York, NY 231 252
2. H.G. Bruenn Clinical notes on the illness and death of President Franklin D. Roosevelt Ann Intern Med 72 1970 579 591
3. M. Gheorghiade, K.F. Adams Jr., and W.S. Colucci Digoxin in the management of cardiovascular disorders Circulation 109 2004 2959 2964
4. M. Gheorghiade, D.J. van Veldhuisen, and W.S. Colucci Contemporary use of digoxin in the management of cardiovascular disorders Circulation 113 2006 2556 2564
5. M. Gheorghiade, F. Zannad, and G. Sopko et al. Acute heart failure syndromes: current state and framework for future research Circulation 112 2005 3958 3968
6. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
7. K.F. Adams Jr., G.C. Fonarow, and C.L. Emerman et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216
8. M. Gheorghiade, W.T. Abraham, and N.M. Albert et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226
9. M. Komajda, O. Hanon, and M. Hochadel et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II Eur Heart J 30 2009 478 486
10. F. Zannad, A. Mebazaa, and Y. Juilliere et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study Eur J Heart Fail 8 2006 697 705
11. O. Chioncel, D. Vinereanu, and M. Datcu et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry Am Heart J 162 2011 142 153
12. F. Oliva, A. Mortara, and G. Cacciatore et al. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome Eur J Heart Fail 14 2012 1208 1217
13. N. Sato, K. Kajimoto, and K. Asai et al. Acute Decompensated Heart Failure Syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data Am Heart J 159 2010 949 955
14. J. Lindenfeld, N.M. Albert, and J.P. Boehmer et al. HFSA 2010 comprehensive heart failure practice guideline J Card Fail 16 2010 e1 e194
15. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
16. C.W. Yancy, M. Jessup, and B. Bozkurt et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
17. M. Gheorghiade, and A. Ambrosy Heart failure in 2010: one step forward, two steps back Nat Rev Cardiol 8 2011 72 73
18. M. Gheorghiade, and E.D. Peterson Improving postdischarge outcomes in patients hospitalized for acute heart failure syndromes JAMA 305 2011 2456 2457
19. M. Gheorghiade, and E. Braunwald A proposed model for initial assessment and management of acute heart failure syndromes JAMA 305 2011 1702 1703
20. M. Gheorghiade, and E. Braunwald Reconsidering the role for digoxin in the management of acute heart failure syndromes JAMA 302 2009 2146 2147
21. T. Akera, S.I. Baskin, T. Tobin, and T.M. Brody Ouabain: temporal relationship between the inotropic effect and the in vitro binding to, and dissociation from, (Na + + K +)- activated ATPase Naunyn Schmiedebergs Arch Pharmacol 277 1973 151 162
22. T.W. Smith, E.M. Antman, P.L. Friedman, C.M. Blatt, and J.D. Marsh Digitalis glycosides: mechanisms and manifestations of toxicity Part III. Prog Cardiovasc Dis 27 1984 21 56
23. T.W. Smith, E.M. Antman, P.L. Friedman, C.M. Blatt, and J.D. Marsh Digitalis glycosides: mechanisms and manifestations of toxicity Part II. Prog Cardiovasc Dis 26 1984 495 540
24. T.W. Smith, E.M. Antman, P.L. Friedman, C.M. Blatt, and J.D. Marsh Digitalis glycosides: mechanisms and manifestations of toxicity Part I. Prog Cardiovasc Dis 26 1984 413 458
25. S.B. Arnold, R.C. Byrd, and W. Meister et al. Long-term digitalis therapy improves left ventricular function in heart failure N Engl J Med 303 1980 1443 1448
26. M. Gheorghiade, J. St. Clair, C. St. Clair, and G.A. Beller Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators J Am Coll Cardiol 9 1987 849 857
27. M. Gheorghiade, V. Hall, J.B. Lakier, and S. Goldstein Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure J Am Coll Cardiol 13 1989 134 142
28. The Captopril-Digoxin Multicenter Research Group Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure JAMA 259 1988 539 544
29. M. Gheorghiade, and D. Ferguson Digoxin. A neurohormonal modulator in heart failure? Circulation 84 1991 2181 2186
30. H. Krum, J.T. Bigger Jr., R.L. Goldsmith, and M. Packer Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure J Am Coll Cardiol 25 1995 289 294
31. D.W. Ferguson, W.J. Berg, J.S. Sanders, P.J. Roach, J.S. Kempf, and M.G. Kienzle Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings Circulation 80 1989 65 77
32. D.J. van Veldhuisen, A.J. Man in 't Veld, and P.H. Dunselman et al. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT) J Am Coll Cardiol 22 1993 1564 1573
33. G.E. Newton, J.H. Tong, A.M. Schofield, A.D. Baines, J.S. Floras, and J.D. Parker Digoxin reduces cardiac sympathetic activity in severe congestive heart failure J Am Coll Cardiol 28 1996 155 161
34. M. Gheorghiade, V.B. Hall, G. Jacobsen, M. Alam, H. Rosman, and S. Goldstein Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors Circulation 92 1995 1801 1807
35. E.J. Eichhorn, and M. Gheorghiade Digoxin Prog Cardiovasc Dis 44 2002 251 266
36. B.F. Uretsky, J.B. Young, F.E. Shahidi, L.G. Yellen, M.C. Harrison, M.K. Jolly for the PROVED Investigative Group Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial J Am Coll Cardiol 22 1993 955 962
37. M. Packer, M. Gheorghiade, and J.B. Young et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting- enzyme inhibitors. RADIANCE Study N Engl J Med 329 1993 1 7
38. E. Lader, D. Egan, S. Hunsberger, R. Garg, S. Czajkowski, and F. McSherry The effect of digoxin on the quality of life in patients with heart failure J Card Fail 9 2003 4 12
39. J.B. Young, M. Gheorghiade, B.F. Uretsky, J.H. Patterson, and K.F. Adams Jr. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme J Am Coll Cardiol 32 1998 686 692
40. R.E. Ward, M. Gheorghiade, J.B. Young, and B. Uretsky Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure J Am Coll Cardiol 26 1995 93 101
41. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure Control Clin Trial 17 1996 77 97
42. A. Ahmed, M.W. Rich, and J.L. Fleg et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial Circulation 114 2006 397 403
43. G.C. Fonarow, N.M. Albert, and A.B. Curtis et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) Circulation 122 2010 585 596
44. S.A. Hunt, W.T. Abraham, and M.H. Chin et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
45. A. Ahmed, M.W. Rich, and T.E. Love et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial Eur Heart J 27 2006 178 186
46. M.L. Slatton, W.N. Irani, and S.A. Hall et al. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol 29 1997 1206 1213
47. K.F. Adams Jr., M. Gheorghiade, B.F. Uretsky, J.H. Patterson, T.A. Schwartz, and J.B. Young Clinical benefits of low serum digoxin concentrations in heart failure J Am Coll Cardiol 39 2002 946 953
48. S.S. Rathore, Y. Wang, and H.M. Krumholz Sex-based differences in the effect of digoxin for the treatment of heart failure N Engl J Med 347 2002 1403 1411
49. K.F. Adams Jr., J.H. Patterson, and W.A. Gattis et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis J Am Coll Cardiol 46 2005 497 504
50. M. Gheorghiade, K. Patel, and G. Filippatos et al. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial Eur J Heart Fail 15 2013 551 559
51. R.C. Bourge, J.L. Fleg, and G.C. Fonarow et al. Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure Am J Med 126 2013 701 708
52. J.M. Testani, M.A. Brisco, and W.H. Tang et al. Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure J Card Fail 19 2013 295 302
53. M. Vaduganathan, and M. Gheorghiade Return of digoxin and recovery of renal function J Card Fail 19 2013 303 305
54. D. Castagno, M.C. Petrie, B. Claggett, and J. McMurray Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure Eur Heart J 33 2012 1137 1141
55. M. Bohm, K. Swedberg, and M. Komajda et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 2010 886 894
56. K. Swedberg, M. Komajda, and M. Bohm et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 2010 875 885
57. K. Swedberg, M. Komajda, M. Bohm, J.S. Borer, I. Ford, and L. Tavazzi Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT) Eur J Heart Fail 12 2010 75 81
58. M. Bohm, J. Borer, and I. Ford et al. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study Clin Res Cardiol 102 2013 11 22
59. V.V. Georgiopoulou, A.P. Kalogeropoulos, and G. Giamouzis et al. Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy Circ Heart Fail 2 2009 90 97
60. J. Butler, I.S. Anand, M.A. Kuskowski, T. Rector, P. Carson, and J.N. Cohn Digoxin use and heart failure outcomes: results from the Valsartan Heart Failure Trial (Val-HeFT) Congest Heart Fail 16 2010 191 195
61. J.V. Freeman, J. Yang, S.H. Sung, M.A. Hlatky, and A.S. Go Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure Circ Cardiovasc Qual Outcomes 6 2013 525 533
62. M.G. Whitbeck, R.J. Charnigo, and P. Khairy et al. Increased mortality among patients taking digoxin-analysis from the AFFIRM study Eur Heart J 34 2013 1481 1488
63. M. Gheorghiade, G.C. Fonarow, and D.J. van Veldhuisen et al. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial Eur Heart J 34 2013 1489 1497
64. D.J. van Veldhuisen, I.C. Van Gelder, A. Ahmed, and M. Gheorghiade Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not? Eur Heart J 34 2013 1468 1470
65. S. Yusuf, J. Wittes, K. Bailey, and C. Furberg Digitalis - a new controversy regarding an old drug. The pitfalls of inappropriate methods Circulation 73 1986 14 18
66. K.M. Williamson, K.A. Thrasher, and K.B. Fulton et al. Digoxin toxicity: an evaluation in current clinical practice Arch Intern Med 158 1998 2444 2449
67. H. Mahdyoon, G. Battilana, H. Rosman, S. Goldstein, and M. Gheorghiade The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988 Am Heart J 120 1990 1189 1194
68. M. Packer, J.R. Carver, R.J. Rodeheffer for the PROMISE Study Research Group Effect of oral milrinone on mortality in severe chronic heart failure N Engl J Med 325 1991 1468 1475
69. M. Metra, E. Eichhorn, and W.T. Abraham et al. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials Eur Heart J 30 2009 3015 3026
70. A.U. Khand, A.C. Rankin, W. Martin, J. Taylor, I. Gemmell, and J.G. Cleland Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol 42 2003 1944 1951
71. I. See, N. Shehab, S.R. Kegler, S.R. Laskar, and D.S. Budnitz Emergency department visits and hospitalizations for digoxin toxicity: United States 2005-2010 Circulation Heart Fail 7 2014 28 34